# clm_6DC2B1698886

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 8,217,000,000 United States dollar  
valid_from: 2021-09-30  
valid_to: 2021-12-31  
published: 2021-11-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_BF8A71350904  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 8,217,000,000 United States dollar", as of 2021-09-30 (until 2021-12-31). Claim clm_6DC2B1698886, https://asof.is/claim/clm_6DC2B1698886, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815421000045/0000318154-21-000045-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-11-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815421000045/0000318154-21-000045-index.htm (primary, SEC EDGAR 10-Q Q3 FY2021, published 2021-11-03)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 8,247,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_6DC2B1698886](/claim/clm_6DC2B1698886.md) | [clm_3DEAF95EF6B0](/claim/clm_3DEAF95EF6B0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.